Regional variation in oral mucosal drug permeability

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 17, Issue 5, 2000, Pages 467-508

  Kurosaki, Yuji ^a   Kimura, Toshikiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Drug absorption; Oral mucosa; Regional variation; Specialized transport system

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; DRUG; HORSERADISH PEROXIDASE; PROTEIN; WATER;

BLOOD FLOW; DIFFUSION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG PENETRATION; DRUG RELEASE; DRUG TRANSPORT; HUMAN; IN VITRO STUDY; KERATINIZATION; MODEL; MOUTH CAVITY; MOUTH MUCOSA; NONHUMAN; REVIEW;

EID: 0033777671     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevtherdrugcarriersyst.v17.i5.20     Document Type: Review

References (159)

1. The permeability of oral mucosa
2. Drug delivery via the mucous membranes of the oral cavity
3. Review: Clinical opportunities provided by the nasal administration of peptides
4. The nasal delivery of systemic drugs
5. Systemic delivery of peptides and proteins across absorptive mucosae
6. Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs
7. Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions
8. Comparative permeability of human vaginal and buccal mucosa to water
9. Diffusion rates of vasopressin through human vaginal and buccal mucosa
10. Biopharmaceutical evaluation of transnasal, sublingual, and buccal disk dosage forms of butorphanol
11. The structural barrier of absorptive mucosae: Site difference of the permeability of fluorescein isothiocyanate-labelled dextran in rabbits
12. Absorption of drugs from the human oral cavity
13. Developments in buccal drug delivery
14. Clinical pharmacokinetics of drugs administered buccally and sublingually
15. Buccal morphine - A new route for analgesia?
16. Buccal and oral availability of naloxine and naltrexone in rats
17. Application of propranolol to the keratinized oral mucosa: Avoidance of first-pass elimination and the use of 1-dodecylazacycloheptan-2-one (Azone) as an absorption enhancer of bioadhesive filmdosage form
18. Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans
19. Comparison of buccal and oral prochlorperazine in the treatment of dizziness associated with nausea and/or vomiting
20. Variable gastric emptying and discontinuities in drug absorption profiles: Dependence of rates and extent of cimetidine absorption on motility phase and pH
21. The effect of in vivo dissolution, gastric emptying rate, and intestinal transit time on the peak concentration and area-under-the-curve of drugs with different gastrointestinal permeabilities
22. The effect of food on the bioavailability of dolasetron mesylate tablets
23. Absorption and bioavailability of oral transmucosal fentanyl citrate
24. Buccal absorption of midazolam: Pharmacokinetics and EEG pharmacodynamics
25. Measurement of blood flow in the oral mucosa and skin of the rhesus monkey using radiolabelled microspheres
26. Measurement of blood flow in the skin and oral mucosa of the rhesus monkey (Macaca mulatta) using laser Doppler flowmetry
27. Buccal absorption of basic drugs and its application as an in vivo model of passive drug transfer through lipid membranes
28. Keratinization
29. Zinc iodide-osmium staining of membrane-coating granules in keratinized and non-keratinized mammalian oral epithelium
30. The surface area of the adult human mouth and thickness of the salivery film covering the teeth and oral mucosae
31. The permeability of skin and oral mucosa to water and horseradish peroxidase as related to the thickness of the permeability barrier
32. Cellular and molecular basis of barrier function in oral epithelium
33. The permeability of keratinized and nonkeratinized oral epithelium to horseradish peroxidase
34. The permeability of keratinized and nonkeratinized oral epithelium to lanthanium in vivo
35. Membrane coating granules in nonkeratinizing oral epithelium
36. Membrane coating granules: The fate of the discharged lamellae
37. Lamellar body-enriched fractions from neonatal mice: Preparative techniques and partial characterization
38. A study of permeability of gingival pocket epithelium to albumin in guinea pigs and Norwegian pigs
39. The permeability of mammalian nonkeratinized oral epithelia to horseradish peroxidase applied in vivo and in vitro
40. Lipids of epidermis and keratinized and non-keratinized oral epithelia
41. Variations in lipids in different layers of porcine epidermis
42. The lipid composition of porcine epidermis and oral epithelium
43. Lipid content and water permeability of skin and oral mucosa
44. Regional variation in content, composition, and organization of porcine epithelial barrier lipids revealed by thin-layer chromatography and transmission electron microscopy
45. In vitro permeability of porcine oral mucosa after epithelial separation, stripping, and hydration
46. Biophysical kinetic modeling of buccal absorption
47. Kinetics of buccal absorption of some carboxylic acids and the correlation of the rate constants and n-heptane:aqueous partition coefficeints
48. A model for steroid transport across biological membranes
49. A method to study the kinetics of oral mucosal drug absorption from solutions
50. A membrane model of the human oral mucosa as derived from buccal absorption performance and physicochemical properties of the β-blocking drugs atenolol and propranolol
51. Preliminary studies of oral mucosal delivery of peptide drugs
52. Human buccal absorption of flurbiprofen
53. In situ perfusion system for oral mucosal absorption in dogs
54. Perfusion cells for studying regional variation in oral-mucosal permeability in humans, I. Kinetic aspects in oral-mucosal absorption of alkylparabens
55. Perfusion cells for studying regional variation in oral-mucosal permeability in humans, 2. A specialized transport mechanism in D-glucose absorption exists in dorsum of tongue
56. Evaluation of laminated muco-adesive patches for buccal drug delivery
57. Regional variation in oral mucosal drug absorption: Permeability and degree of keratinization in hamster oral cavity
58. Improvement of release rate of diclofenac from oro-muco-adhesive film dosage form by incorporating electrolytes and its effects on mucosal absorption
59. Methods for assessing the buccal mucosa as a route of drug delivery
60. The permeability of human oral mucosa and skin to water
61. In vitro studies on enhancing effect of sodium glycocholate on transbuccal permeation of morphine hydrochloride
62. Active electrolyte transport in mammalian buccal mucosa
63. Interaction of percutaneous absorption enhancer with stratum corneum of hamster cheek pouch; An electrophysiological study
64. Permeation of unfolded basic fibroblast growth factor (bFGF) across rabbit buccal mucosa - Does unfolding of bFGF enhance transport?
65. Transbuccal delivery of acyclovir, I. In vitro determination of routes of buccal transport
66. Cultured buccal epithelium: An in vitro model derived from the hamster pouch for studying drug transport and metabolism
67. Buccal tissues and cell culture
68. Carrier-mediated transport of monocarboxylic acids in primary cultured epithelial cells from rabbit oral mucosa
69. Filter-grown TR146 cells as an in vitro model of human buccal epithelial permeability
70. Lectins for drug delivery within the oral cavity - Investigation of lectin binding to oral mucosa
71. Carrier-mediated transport systems for glucose in mucosal cells of human oral cavity
72. Characteristics of four new human cell lines derived from squamous cell carcinomas of the head and neck
73. TR146 cells grown on filters as a model of human buccal epithelium, III. Permeability enhancement by different pH values, different osmolality values, and bile salts
74. TR146 cells grown on filters as a model of human buccal epithelium: Permeability of fluorescein isothiocyanate-labelled dextrans in the presence of sodium glycocholate
75. Enhanced permeability of keratinized oral-mucosa to salicylic acid with 1-dodecylazacycloheptan-2-one (Azone). In vitro studies in hamster cheek pouch
76. Use of lipid disperse systems in transdermal drug delivery: Comparative study of flufenamic acid permeation among rat abdominal skin, silicon rubber membrane, and stratum corneum sheet isolated from hamster cheek pouch
77. A study into the mucosal absorption of isosorbide dinitrate at different intraoral sites
78. Evaluation of a method to study the uptake of prednisolone sodium phosphate from different oral mucosal sites
79. The absorption of sugars from the human oral cavity
80. Effect of calcium ions on the uptake of sugars through the human buccal mucosa
81. Absorption of nicotinic acid and nicotinamide across human buccal mucosa
82. Absorption of aminoacids from the human buccal cavity
83. Thiamine absorption across human buccal mucosa
84. Absorption of glutathione from the gastrointestinal tract
85. Existence of a specialized absorption mechanism for cefadroxil, an aminocephalosporin antibiotic, in the human oral cavity
86. Carrier-mediated approaches for oral drug delivery
87. Mechanisms of intestinal absorption: Unstirred layer resistance and membrane transport
88. Carrier-mediated absorption of salicylic acids from hamster cheek pouch mucosa
89. Studies on drug absorption from oral cavity: Physicochemical factors affecting absorption from hamster cheek pouch
90. Studies on drug absorption from oral cavity. II. Influence of the unstirred water layer on absorption from hamster cheek pouch in vitro and in vivo
91. FDA perspective on peptide formulation and stability issues
92. Buccal absorption of protirelin: An effective way to stimulate thyrotropin and prolactin
93. New mucosal dosage form of insulin
94. Comparison of nasal, rectal, buccal, sublingual, and intramuscular insulin efficacy and the effects of a bile salt absorption promoter
95. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery
96. In vitro release and permeation of oxytocin from a mucoadhesive buccal patch
97. Absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) from rat nasal mucosa
98. Nasal delivery of peptides: An in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium
99. Permeation and pathways of human calcitonin (hCT) across excised bovine nasal mucosa
100. Efficacy, safety, and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs
101. Absorption enhancers as tools to determine the route of nasal absorption of peptides
102. Studies of drug delivery systems for a therapeutic agent used in osteoporosis, II. Enhanced absorption of elcatonin from nasal mucosa in rabbits
103. In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery
104. Mucosal drug delivery using cellulose derivatives as a functional polymer
105. Enhancement of nasal absorption of insulin using chitosan nanoparticles
106. The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits
107. Pulmonary drug delivery: Physiologic and mechanistic aspects
108. Tracheal barrier and the permeability of hydrophilic drugs and dipeptides
109. Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies
110. Pharmacodynamics and pharmacokinetics of recombinant human granulocyte colony-stimulating factor (rhG-CSF) after administration of a rectal dosage vehicle
111. Studies of drug delivery systems for a therapeutic agent used in osteoporosis, I. Pharmacodynamics (hypocalcemic effect) of elcatonin in rabbits following rectal administration of hollow-type suppositories containing elcatonin
112. Penetration of human vaginal and buccal mucosa by 4.4-kd and 12-kd fluorescein-isothiocyanate-labeled dextrans
113. 2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery
114. Transport of peptide and protein drugs across biological membranes
115. Transmucosal delivery of leucine enkephalin: Stabilization in rabbit enzyme extracts and enhancement of permeation through mucosae
116. Mechanistic insights to buccal delivery of proteiaceous substances
117. The influence of peptide structure on transport across Caco-2 cells, II. Peptide bond modification which results in improved permeability
118. The relationship between peptide structure and transport across epithelial cell monolayers
119. Aminopeptidase activity in homogenates of various absorptive mucosae in the albino rabbit: Implications in peptide delivery
120. Buccal drug absorption, I. Comparative levels of esterase and peptidase activities in rat and hamster buccal and intestinal homogenates
121. The effect of additives on the oral mucosal absorption of human calcitonin in rats
122. The effect of bile salts on the oral mucosal absorption of human calcitonin in rats
123. Buccal absorption of insulin in the dog
124. Visualization of enhancing effects of bile salts on buccal penetration
125. Oramucosal delivery of LHRH: Pharmacokinetic studies of controlled and enhanced transmucosal permeation
126. In vivo buccal delivery of the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs
127. Effects of the penetration enhancer glycodeoxycholate on the lipid integrity in porcine buccal epithelium in vitro
128. In vivo buccal delivery of fluorescein isothiocyanate-dextran 4400 with glycodeoxycholate as an absorption enhancer in pigs
129. Screening of cationic compounds as an absorption enhancer for nasal drug delivery
130. The effects of permeabilizers on the in vitro penetration of propranolol through porcine buccal epithelium
131. Effect of cod-liver oil extract on the buccal permeation of ergotamine tartrate
132. The enhancing mechanism of capric acid (C10) from a suppository on rectal drug absorption through a paracellular pathway
133. Enhancing effect of 1-dodecylazacycloheptan-2-one (Azone) on the absorption of salicylic acid from keratinized oral-mucosa and the duration of enhnacement in vivo
134. The effect of methylated beta-cyclodextrins on the tight junctions of the rat nasal respiratory epithelium: Electron microscopic and confocal laser scanning microscopic visualization studies
135. Effects of surfactants on the absorption of salicylic acid from hamster cheek pouch as a model of keratinized oral mucosa
136. Regional variation in the structure and permeability of oral mucosa and skin
137. Cellular and molecular basis of barrier function in oral epithelium
138. Effect of N-alkyl-azocycloheptan-2-ones including Azone on the thermal behavior of human stratum corneum
139. Effect of some penetration enhancers on epithelial membrane lipid domains: Evidence from fluorescence spectroscopy studies
140. An in vivo dog model for studying recovery kinetics of the buccal mucosa permeation barrier after exposure to permeation enhancers: Apparent evidence of effective enhancement without tissue damage
141. Evaluation of enhancers to increase nasal absorption using Ussing chamber technique
142. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery
143. Release of isosorbide dinitrate from polymer film dosage forms and absorption of this drug through the oral mucosa of rats
144. Formulation and evaluation of controlled release Eudragit buccal patches
145. Evaluation of a mucoadhesive buccal patch for delivery of peptides: In vitro screening of bioadhesion
146. Transmucosal delivery of oxytocin to rabbits using a mucoadhesive buccal patch
147. Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: Effect of formulation variables on drug release and mucoadhesive performance
148. Bioavailability of morphine after administration of a new bioadhesive buccal tablet
149. In vitro oral mucosal absorption of liposomal triamcinolone acetonide
150. Comparative study of buccoadhesive formulations and sublingual capsules of nifedipine
151. Influence of the application site on bioadhesion and slow-release characteristics of a bioadhesive buccal slow-release tablet of miconazole
152. Formulation and characterisation of a buccoadhesive erodible tablet for the treatment of oral lesions
153. Human transbuccal absorption of diclofenac sodium from a prototype hydrogel delivery device
154. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine
155. Pharmacokinetics of a single dose of buccal testosterone
156. Pharmacokinetic characteristics, efficacy, and safety of buccal testosterone in hypogonadal males: A pilot study
157. Absorption of clonazepam after intranasal and buccal administration